Cisplatin and its platinum analogs, carboplatin and oxaliplatin, are some of the most widely
used cancer chemotherapeutics. Although cisplatin and carboplatin are used primarily in …

The development of new drug regimens that allow rapid, sterilizing treatment of tuberculosis
has been limited by the complexity and time required for genetic manipulations in …

Combination chemotherapies have been a mainstay in the treatment of disseminated
malignancies for almost 60 y, yet even successful regimens fail to cure many patients. Although …

Transposon-insertion sequencing (TIS) is a powerful approach for deciphering genetic
requirements for bacterial growth in different conditions, as it enables simultaneous genome-wide …

The prevailing approach to addressing secondary drug resistance in cancer focuses on treating
the resistance mechanisms at relapse. However, the dynamic nature of clonal evolution, …

Small molecules can affect many cellular processes. The disambiguation of these effects to
identify the causative mechanisms of cell death is extremely challenging. This challenge …

The coupling of high-density transposon mutagenesis to high-throughput DNA sequencing (transposon-insertion
sequencing) enables simultaneous and genome-wide assessment of …

Recent tumor sequencing data suggest an urgent need to develop a methodology to directly
address intratumoral heterogeneity in the design of anticancer treatment regimens. We use …

The current clinical application of combination chemotherapy is guided by a historically
successful set of practices that were developed by basic and clinical researchers 50–60 years …

Identifying mechanisms of drug action remains a fundamental impediment to the development
and effective use of chemotherapeutics. Here we describe an RNA interference (RNAi)–…